Diagnosis and treatment of patients with pouchitis

Drugs

Volumn 63, Issue 5, 2003, Pages 453-461

  Shen, Bo ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; AZATHIOPRINE; BISMUTH SALICYLATE; BUDESONIDE; BUTYRIC ACID; CIPROFLOXACIN; CLARITHROMYCIN; CORTICOSTEROID; CORTIFORM; DOXYCYCLINE; ERYTHROMYCIN; GLUTAMINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; PLACEBO; PROBIOTIC AGENT; RIFAXIMIN; SALAZOSULFAPYRIDINE; SHORT CHAIN FATTY ACID; SPASMOLYTIC AGENT; TETRACYCLINE; VSL 3; YOVIS;

ALGORITHM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BIFIDOBACTERIUM; CLINICAL ARTICLE; CLINICAL TRIAL; COLITIS; COLORECTAL SURGERY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; CROSSOVER PROCEDURE; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; DYSGEUSIA; GASTROINTESTINAL ENDOSCOPY; HUMAN; ILEITIS; ILEUM POUCH; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE ANASTOMOSIS; IRRITABLE COLON; LACTOBACILLUS; NAUSEA; NONHUMAN; PERIPHERAL NEUROPATHY; POSTOPERATIVE COMPLICATION; PROCTOCOLECTOMY; REVIEW; SEIZURE; SIDE EFFECT; STREPTOCOCCUS SALIVARIUS; SUPPOSITORY; SYMPTOMATOLOGY; TASTE DISORDER; TREATMENT PLANNING; ULCERATIVE COLITIS; VOMITING;

ACUTE DISEASE; ADJUVANTS, IMMUNOLOGIC; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; CHRONIC DISEASE; DRUG ADMINISTRATION SCHEDULE; ENDOSCOPY, GASTROINTESTINAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; POUCHITIS; RANDOMIZED CONTROLLED TRIALS;

BIFIDOBACTERIUM; LACTOBACILLUS; STREPTOCOCCUS; STREPTOCOCCUS SALIVARIUS;

EID: 0037228495     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200363050-00002     Document Type: Review

References (44)

1. Sandborn WJ. Pouchitis following ileal pouch-anal anastomosis: definition, pathogenesis, and treatment. Gastroenterology 1994; 107: 1856-60
2. Zuccaro G, Fazio VW, Church JM, et al. Pouch ileitis. Dig Dis Sci 1989; 34: 1505-10
3. Fazio VW, Ziv Y, Church JM, et al. Ileal pouch-anal anastomosis complications and function in 1005 patients. Ann Surg 1995; 222: 120-7
4. Penna C, Dozois R, tremaine W, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut 1996; 38: 234-9
5. Shepherd NA, Hulten L, Tytgat GNJ, et al. Workshop: pouchitis. Int J Colorectal Dis 1989; 4: 205-29
6. Lohmuller JL, Perberton JH, Dozois RR, et al. Pouchitis and extraintestinal manifestations of inflammatory bowel disease after ileal pouch-anal anastomosis. Ann Surg 1990; 211: 622-9
7. Penna C, Tiret E, Kartheuser A, et al. Function of ileal J pouch-anal anastomosis in patients with familial adenomatous polyposis. Br J Surg 1993; 80: 765-7
8. Tjandra JJ, Fazio VW, Church JM, et al. Similar functional results after restorative proctocolectomy in patients with familial adenomatous polyposis and mucosal ulcerative colitis. Am J Surg 1993; 165: 322-5
9. Dozois RR, Goldberg SM, Rothenberger DA, et al. Workshop: pouchitis. Int J Colorectal Dis 1986; 1: 2-19
10. Schmidt CM, Lazenby AJ, Hendrickson RJ, et al. Preoperative terminal ileal and colonic resection histopathology predicts risk of pouchitis in patients after ileoanal pull-through procedure. Ann Surg 1998; 227: 654-65
11. Meagher AP, Farouk R, Dozois RR, et al. J ileal pouch-anal anastomosis for chronic ulcerative colitis: complications and long-term outcomes in 1310 patients. Br J Surg 1998; 85: 800-3
12. Yang T, Oresland T, Jarnerot G, et al. Perinuclear anti-neutrophil cytoplasmic antibody in pouchitis after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. Scand J Gastroenterol 1996; 31: 594-8
13. Sandborn WJ, Landers CJ, Tremaine WJ, et al. Antineutrophil cytoplasmic antibody correlates with chronic pouchitis after ileal pouch-anal anastomosis. Am J Gastroenterol 1995; 90: 740-7
14. Fleshner PR, Vasiliauskas EA, Kam LY, et al. High level perinuclear antineutrophil cytoplasmic antibody (pANCA) in ulcerative colitis patients before colectomy predicts the development of chronic pouchitis after ileal pouch-anal anastomosis. Gut 2001; 49: 671-7
15. Shen B, Achkar J-P, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology 2001; 121: 261-7
16. 111In-labeled granulocytes. Gastroenterology 1993; 104: 981-8
17. Moskowitz RL, Shepherd NA, Nicholls RJ. An assessment of inflammation in the reservoir after restorative proctocolectomy with ileoanal ileal reservoir. Int J Colorectal Dis 1986; 1: 167-74
18. Petras RE. Role of the pathologist in evaluating chronic pouchitis. In: Bayless TM, Hanauer SB, editors. Advanced therapy of inflammatory bowel disease. 1st ed. Hamilton, (ON): BC Decker, 2001: 229-32
19. Pemberton JH. The problem with pouchitis [editorial]. Gastroenterology 1993; 104: 1209-11
20. Shen B, Achkar JP, Lashner BA, et al. Irritable pouch syndrome: a new category of diagnosis for symptomatic patients with ileal pouch-anal anastomosis. Am J Gastroenterol 2002; 97: 972-7
21. Heuschen UA, Autschbach F, Allemeyer EH, et al. Long-term follow-up after ileoanal pouch procedure: algorithm for diagnosis, classification, and management of pouchitis. Dis Colon Rectum 2001; 44: 487-99
22. Sandborn WJ, Tremaine WJ, Batts KP, et al. Pouchitis after ileal pouch-anal anastomosis: a pouchitis disease activity index. Mayo Clin Proc 1994: 69: 409-15
23. Gionchetti P, Rizzello F, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment resistant pouchitis. Aliment Pharmacol Ther 1999; 13: 713-8
24. Gionchetti P, Rizzello F, Venturi A, et al. Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 2000; 119: 305-9
25. Tremaine WJ, Sandborn WJ, Wolff BG, et al. Bismuth carbomer foam enemas for active chronic pouchitis: a randomized, double-blind, placebo-controlled trial. Aliment Pharmacol Ther 1997; 11: 1041-6
26. Shen B, Achkar JP, Lashner BA, et al. A randomized trial of ciprofloxacin and metronidazole in treating acute pouchitis. Inflamm Bowel Dis 2001; 7: 301-5
27. Gionchetti P, Rizzollo F, Venturi A, et al. Prophylaxis of pouchitis onset with probiotic therapy: a double blind, placebo controlled trial [abstract]. Gastroenterology 2000; 118: A1214
28. Sandborn WJ, Tremaine WJ, Batts KP, et al. Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis. Dig Dis Sci 1995; 40: 1474-83
29. Sambuelli A, Boerr L, Negreira S, et al. Budesonide enema in pouchitis: a double-blinded, double dummy, controlled trial. Aliment Pharmacol Ther 2002; 16: 27-34
30. Sandborn WJ. Pouchitis: risk factors, frequency, natural history. classification, and public health prospective. In: McLeod RS, Martin F, Sutherland LR, et al., editors. Trends in inflammatory bowel disease 1996. Lancaster, UK: Kluwer Academic Publishers, 1997: 51-63
31. Sandborn WJ. Pouchitis in the Kock continent ileostomy and the ileoanal pouch. In: Kirsner JB, editor. Inflammatory bowel disease. 5th ed. Philadelphia (PA): WB Saunders Company, 1999: 736-47
32. Shen B, Lashner BA, Achkar JP, et al. Modified pouchitis disease activity index (mPDAI): a new approach to the diagnosis of pouchitis. Dis Colon Rectum. In press
33. Shen B, Shermock KM, Achkar JP, et al. A cost-effectiveness analysis of diagnostic strategies in symptomatic patients with ileal pouch-anal anastomosis [abstract]. Am J Gastroenterol 2001; 96: A975
34. Ricart E, Panccione R, Loftus EV, et al. Successful management of Crohn disease of the ileoanal pouch with infliximab. Gastroenterology 1999; 117: 429-32
35. Madden MV, McIntyre AS, Nicholls RJ. Double-blinded crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994; 39: 1193-6
36. Mignon M, Stettler C, Philips SF. Pouchitis: a poorly understood entity. Dis Colon Rectum 1995; 38: 100-3
37. Sartor RB. Probiotics in chronic pouchitis: restoring luminal microbial balance. Gastroenterology 2000; 119: 584-5
38. Hurst RD, Molinari M, Chung TP, et al. Prospective study of the incidence, timing, and treatment of pouchitis in 104 consecutive patients after restorative proctocolectomy. Arch Surg 1996; 131: 497-502
39. Mowschenson PM, Critchlow JF, Peppercorn MA. Ileoanal pouch operation: long-term outcome with or without diverting ileostomy. Arch Surg 2000; 135: 463-5
40. Hurst RD, Chung TP, Rubin M, et al. Implications of acute pouchitis on the long-term functional results after restorative proctocolectomy. Inflamm Bowel Dis 1998; 4: 280-4
41. Madiba TE, Bartolo DC. Pouchitis following restorative proctocolectomy for ulcerative colitis: incidence and therapeutic outcome. J R Coll Surg Edinb 2001; 46: 334-7
42. Wischmeyer P, Pemberton JH, Philips SF. Chronic pouchitis after ileal pouch-anal anastomosis: responses to butyrate and glutamine suppositories in a pilot study. Mayo Clin Proc 1993; 68: 978-81
43. Gionchetti P, Rizzello R, Venturi A, et al. Antibiotic combination therapy in patients with chronic, treatment-resistant pouchitis. Aliment Pharmacol Ther 1999; 13: 713-8
44. Mimura T, Rizzello R, Helwig U, et al. Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther 2002; 16: 909-17